UBS Group’s IQ Global Equity R&D Leaders ETF WRND Stock Holding History

UBS Group’s Portfolio WRND Stock Details WRND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-106	Closed	-$3.82K	–	11239
2025 Q3	$3.82K	Sell	106 -54	-34%	-$1.84K	﹤0.01%	9005
2025 Q2	$5.19K	Hold	160	–	–	﹤0.01%	9199
2025 Q1	$4.72K	Hold	160	–	–	﹤0.01%	9071
2024 Q4	$4.71K	Hold	160	–	–	﹤0.01%	8732
2024 Q3	$4.84K	Buy	160 +90	+129%	+$2.64K	﹤0.01%	8115
2024 Q2	$2.06K	Hold	70	–	–	﹤0.01%	8433
2024 Q1	$2.01K	Sell	70 -210	-75%	-$5.72K	﹤0.01%	7998
2023 Q4	$7.35K	Hold	280	–	–	﹤0.01%	7629
2023 Q3	$6.72K	Buy	+280	New	+$6.99K	﹤0.01%	7277
2023 Q1	–	Sell	-2	Closed	-$40	–	10467
2022 Q4	$40	Buy	+2	New	+$40	﹤0.01%	10496

Other funds holding WRND

NYLIM

New York Life Investment Management New York $14.3B AUM 34.42% 1-Year Est. Return

UBS Group's WRND Position: Q4 2025 in Review

UBS Group sold out of IQ Global Equity R&D Leaders ETF (WRND) in Q4 2025, closing a stake of 106 shares — an estimated $3.82K sold.

UBS Group first reported a position in WRND in Q4 2022 and held it in 10 quarters. The position peaked at $7.35K in Q4 2023. 1 fund tracked by Wall St. Rank holds WRND as of Q4 2025.

UBS Group reported no remaining IQ Global Equity R&D Leaders ETF position as of Q4 2025 after selling out during the quarter.
UBS Group sold 106 IQ Global Equity R&D Leaders ETF shares in Q4 2025, an estimated $3.82K.
UBS Group first reported a position in IQ Global Equity R&D Leaders ETF in Q4 2022 and held it in 10 quarters.
UBS Group's IQ Global Equity R&D Leaders ETF position peaked at $7.35K in Q4 2023.
1 fund tracked by Wall St. Rank held IQ Global Equity R&D Leaders ETF as of Q4 2025.

Based on UBS Group's 13F filing for Q4 2025, filed 29 Jan 2026.